Research found that the cholesterol drug Vytorin, which combines
Zetia with the statin Zocor, is no more effective than a statin
alone at preventing plaque from growing in arteries.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.